Investigation of DNA Damage and Cell-Cycle Distribution in Human Peripheral Blood Lymphocytes under Exposure to High Doses of Proton Radiotherapy

This study systematically investigates how a single high-dose therapeutic proton beam versus X-rays influences cell-cycle phase distribution and DNA damage in human peripheral blood lymphocytes (HPBLs). Blood samples from ten volunteers (both male and female) were irradiated with doses of 8.00, 13.6...

Full description

Bibliographic Details
Main Author: Justyna Miszczyk
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Biology
Subjects:
Online Access:https://www.mdpi.com/2079-7737/10/2/111
_version_ 1797415865475399680
author Justyna Miszczyk
author_facet Justyna Miszczyk
author_sort Justyna Miszczyk
collection DOAJ
description This study systematically investigates how a single high-dose therapeutic proton beam versus X-rays influences cell-cycle phase distribution and DNA damage in human peripheral blood lymphocytes (HPBLs). Blood samples from ten volunteers (both male and female) were irradiated with doses of 8.00, 13.64, 15.00, and 20.00 Gy of 250 kV X-rays or 60 MeV protons. The dose–effect relations were calculated and distributed by plotting the frequencies of DNA damage of excess Premature Chromosome Condensation (PCC) fragments and rings in the G2/M phase, obtained via chemical induction with calyculin A. The Papworth’s <i>u </i>test was used to evaluate the distribution of DNA damage. The study shows that high doses of protons induce HPBL DNA damage in the G2/M phase differently than X-rays do. The results indicate a different distribution of DNA damage following high doses of irradiation with protons versus photons between donors, types of radiation, and doses. The proliferation index confirms the impact of high doses of mitosis and the influence of radiotherapy type on the different HPBL response. The results illuminate the cellular and molecular mechanisms that underlie differences in the distribution of DNA damage and cell-cycle phases; these findings may yield an improvement in the efficacy of the radiotherapies used.
first_indexed 2024-03-09T05:55:39Z
format Article
id doaj.art-c306b418632f407b9c0614f8f40a872d
institution Directory Open Access Journal
issn 2079-7737
language English
last_indexed 2024-03-09T05:55:39Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Biology
spelling doaj.art-c306b418632f407b9c0614f8f40a872d2023-12-03T12:14:16ZengMDPI AGBiology2079-77372021-02-0110211110.3390/biology10020111Investigation of DNA Damage and Cell-Cycle Distribution in Human Peripheral Blood Lymphocytes under Exposure to High Doses of Proton RadiotherapyJustyna Miszczyk0Department of Experimental Physics of Complex Systems, Institute of Nuclear Physics Polish Academy of Sciences, 31-342 Krakow, PolandThis study systematically investigates how a single high-dose therapeutic proton beam versus X-rays influences cell-cycle phase distribution and DNA damage in human peripheral blood lymphocytes (HPBLs). Blood samples from ten volunteers (both male and female) were irradiated with doses of 8.00, 13.64, 15.00, and 20.00 Gy of 250 kV X-rays or 60 MeV protons. The dose–effect relations were calculated and distributed by plotting the frequencies of DNA damage of excess Premature Chromosome Condensation (PCC) fragments and rings in the G2/M phase, obtained via chemical induction with calyculin A. The Papworth’s <i>u </i>test was used to evaluate the distribution of DNA damage. The study shows that high doses of protons induce HPBL DNA damage in the G2/M phase differently than X-rays do. The results indicate a different distribution of DNA damage following high doses of irradiation with protons versus photons between donors, types of radiation, and doses. The proliferation index confirms the impact of high doses of mitosis and the influence of radiotherapy type on the different HPBL response. The results illuminate the cellular and molecular mechanisms that underlie differences in the distribution of DNA damage and cell-cycle phases; these findings may yield an improvement in the efficacy of the radiotherapies used.https://www.mdpi.com/2079-7737/10/2/111human peripheral blood lymphocytes (HPBLs)proton radiotherapypremature chromosome condensation (PCC) testX-rayscell-cycleDNA damage
spellingShingle Justyna Miszczyk
Investigation of DNA Damage and Cell-Cycle Distribution in Human Peripheral Blood Lymphocytes under Exposure to High Doses of Proton Radiotherapy
Biology
human peripheral blood lymphocytes (HPBLs)
proton radiotherapy
premature chromosome condensation (PCC) test
X-rays
cell-cycle
DNA damage
title Investigation of DNA Damage and Cell-Cycle Distribution in Human Peripheral Blood Lymphocytes under Exposure to High Doses of Proton Radiotherapy
title_full Investigation of DNA Damage and Cell-Cycle Distribution in Human Peripheral Blood Lymphocytes under Exposure to High Doses of Proton Radiotherapy
title_fullStr Investigation of DNA Damage and Cell-Cycle Distribution in Human Peripheral Blood Lymphocytes under Exposure to High Doses of Proton Radiotherapy
title_full_unstemmed Investigation of DNA Damage and Cell-Cycle Distribution in Human Peripheral Blood Lymphocytes under Exposure to High Doses of Proton Radiotherapy
title_short Investigation of DNA Damage and Cell-Cycle Distribution in Human Peripheral Blood Lymphocytes under Exposure to High Doses of Proton Radiotherapy
title_sort investigation of dna damage and cell cycle distribution in human peripheral blood lymphocytes under exposure to high doses of proton radiotherapy
topic human peripheral blood lymphocytes (HPBLs)
proton radiotherapy
premature chromosome condensation (PCC) test
X-rays
cell-cycle
DNA damage
url https://www.mdpi.com/2079-7737/10/2/111
work_keys_str_mv AT justynamiszczyk investigationofdnadamageandcellcycledistributioninhumanperipheralbloodlymphocytesunderexposuretohighdosesofprotonradiotherapy